Patient Capital Management, LLC has filed a new report detailing its investment holdings as of September 30, 2026. The filing reveals a total value of approximately $3.1 billion, indicating the firm's active engagement in the investment landscape. This update is significant for investors and industry observers as it sheds light on the company's strategic positioning in various sectors.
Founded and based in Baltimore, Maryland, Patient Capital Management operates under the Central Index Key (CIK) number 0001854794. The firm specializes in managing investments and has been active in filing various reports with the SEC, including the recent 13F-HR submission on November 12, 2026. This filing is part of a series of reports that the firm has submitted, highlighting its ongoing investment strategies.
The latest filing indicates that Patient Capital Management holds a diverse portfolio, with significant investments in well-known companies. Notably, the firm has substantial positions in major technology and healthcare firms, including Amazon, Alphabet, and Meta Platforms. The filing outlines a total of 41 different holdings, showcasing a strategic approach to investment management.
According to the filing, the total value of the holdings reported is $3,145,732,945. This figure reflects the firm's commitment to maintaining a robust investment portfolio. The report also notes that there are no other included managers, emphasizing that Patient Capital Management is solely responsible for these holdings.
This update may have implications for various stakeholders, including investors and market analysts. The significant value of the reported holdings suggests a strong confidence in the selected companies' performance. Additionally, the filing may influence investor sentiment and strategies as they assess the firm's investment choices and overall market trends.
Looking ahead, it remains to be seen how Patient Capital Management will adjust its investment strategies in response to market conditions. The firm has a history of active engagement in the investment community, and further filings are expected as it continues to navigate the evolving landscape.
Details were not available in the SEC filing regarding specific future actions or strategies that Patient Capital Management may undertake following this report.
Read Next
Silvia, Inc. updates stock compensation for CEO Pompliano
FG Communities Holdings declares quarterly cash dividend
Solmate Infrastructure Expands into AI Compute Services
Bitmine Immersion Technologies announces operational update
ASOF Investment Management Acquires 13,587 Shares of Claritev
Belite Bio CMO Scholl Hendrik Peter Sells 2,000 Shares








